QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=D843C6311E59698C2DBE7AF30DE6C714;jsessionid=6C5D62AE93482B6A6478C1D31B2CD075;jsessionid=86B0E0C732792DFC74B9E6F75080E21A;jsessionid=A048716453AE9E862B253EFC0AB2139F (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=D843C6311E59698C2DBE7AF30DE6C714;jsessionid=6C5D62AE93482B6A6478C1D31B2CD075;jsessionid=86B0E0C732792DFC74B9E6F75080E21A;jsessionid=A048716453AE9E862B253EFC0AB2139F